There is no denying the impact of CRISPR-Cas9 technology
as a molecular tool for understanding basic biology, but
recent advances push the gene-editing platform from analytic
resource to therapeutic solution. This webinar will present
efforts to address the challenges of genome modification as
therapy, whether by improving fidelity, introducing fail-safes, or
working ex vivo.
Speaker Information:
Natalia Gomez-Ospina, MD, PhD
Taube Pediatric Neurodegenerative Disease Scholar
Assistant Professor, Dept. of Pediatrics
Divisions of Medical Genetics & Stem Cell and Regenerative Medicine
Stanford University
Developing gene-based therapies for metabolic and neurodegenerative diseases.
Pranam Chatterjee, PhD
Carlos M. Varsavsky Research Fellow
Harvard Medical School | MIT Media Lab
Next generation CRISPR technologies for potential clinical use.
Sponsored by
Interested in sponsoring a webinar?
Click here to contact our friendly sales team.
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy